Fundz
Back to Investors

Track Novartis Venture Fund's Investment Activity

Get real-time alerts when Novartis Venture Fund makes new investments. Full investor profiles, co-investor networks, and deal history are available on Pro plans.

Compare PlansProFull access from $59/mo
N

Novartis Venture Fund

Corporate VC
Total Deals
21
Recent (90d)
1
Total Capital
$1.8B
Co-Investors
114
F

Fore Biotherapeutics

BiotechnologyPhiladelphia, United States
series d
$67.4M

Jul 7, 2026

S

Sidewinder Therapeutics

Biotechnology
series b
$137.0M

Apr 8, 2026

E

EpiBiologics

Biotechnology
series b
$107.0M

Jan 8, 2026

F

FoRx Therapeutics

BiotechnologyBasel, Switzerland
series a
$50.0M

Dec 18, 2025

P

Protego Biopharma

Biotechnology
series b
$130.0M

Dec 1, 2025

16+ more investments

View all 21 deals by Novartis Venture Fund

ProFull deal history requires Pro

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. Trusted by firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz tracks 200,000+ companies and 40,000+ investors.